Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Egyptian (CASE/EGX) Healthcare Sector Analysis

UpdatedJan 24, 2026
DataAggregated Company Financials
Companies17
  • 7D2.5%
  • 3M-8.1%
  • 1Y70.1%
  • YTD-3.5%

Over the last 7 days, the Healthcare industry has risen 2.5%, driven by gains from Ibnsina Pharma of 11%. This takes the industry's 12 month performance to a gain of 70%. Earnings are forecast to grow by 25% annually.

Sector Valuation and Performance

Has the Egyptian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Jan 2026ج.م91.0bج.م115.9bج.م5.5b16.1x16.5x0.8x
Mon, 22 Dec 2025ج.م89.7bج.م115.5bج.م5.4b15.6x16.6x0.8x
Wed, 19 Nov 2025ج.م88.6bج.م113.6bج.م5.3b16.4x16.6x0.8x
Fri, 17 Oct 2025ج.م87.1bج.م108.4bج.م5.1b15.9x17x0.8x
Sun, 14 Sep 2025ج.م73.5bج.م107.3bج.م5.0b15.4x14.7x0.7x
Tue, 12 Aug 2025ج.م64.7bج.م99.1bج.م4.4b13.5x14.8x0.7x
Thu, 10 Jul 2025ج.م58.7bج.م98.5bج.م4.3b12.5x13.7x0.6x
Sat, 07 Jun 2025ج.م56.5bج.م97.1bج.م4.0b10.5x14.2x0.6x
Mon, 05 May 2025ج.م55.1bج.م88.3bج.م3.9b9.5x14x0.6x
Wed, 02 Apr 2025ج.م53.6bج.م88.3bج.م3.9b9.1x13.6x0.6x
Fri, 28 Feb 2025ج.م49.7bج.م86.4bج.م3.9b10.9x12.6x0.6x
Sun, 26 Jan 2025ج.م49.0bج.م77.9bج.م3.4b17.8x14.6x0.6x
Tue, 24 Dec 2024ج.م46.7bج.م77.9bج.م3.4b18.4x13.9x0.6x
Thu, 21 Nov 2024ج.م45.8bج.م76.9bج.م3.2b7x14.2x0.6x
Sat, 19 Oct 2024ج.م47.9bج.م69.2bج.م2.9b10.5x16.6x0.7x
Mon, 16 Sep 2024ج.م35.4bج.م69.4bج.م3.0b7.6x11.9x0.5x
Wed, 14 Aug 2024ج.م34.3bج.م63.7bج.م3.1b7.6x11.1x0.5x
Fri, 12 Jul 2024ج.م34.9bج.م63.6bج.م3.2b7.6x11x0.5x
Sun, 09 Jun 2024ج.م33.3bج.م63.5bج.م3.1b7.6x10.7x0.5x
Tue, 07 May 2024ج.م33.0bج.م58.0bج.م2.5b11x13.5x0.6x
Thu, 04 Apr 2024ج.م36.6bج.م57.6bج.م2.9b8.9x12.8x0.6x
Sat, 02 Mar 2024ج.م39.2bج.م52.7bج.م3.0b10.5x13x0.7x
Mon, 29 Jan 2024ج.م34.2bج.م52.6bج.م3.0b10.5x11.4x0.7x
Wed, 27 Dec 2023ج.م31.4bج.م51.4bج.م2.9b9.8x10.9x0.6x
Fri, 24 Nov 2023ج.م31.6bج.م46.5bج.م2.7b10.9x11.6x0.7x
Sun, 22 Oct 2023ج.م26.4bج.م45.6bج.م2.5b10.5x10.5x0.6x
Tue, 19 Sep 2023ج.م25.8bج.م46.2bج.م2.6b10.3x9.9x0.6x
Thu, 17 Aug 2023ج.م24.7bج.م45.7bج.م2.6b10x9.4x0.5x
Sat, 15 Jul 2023ج.م25.0bج.م42.7bج.م2.6b9.8x9.7x0.6x
Mon, 12 Jun 2023ج.م26.3bج.م43.1bج.م2.7b9.7x9.8x0.6x
Wed, 10 May 2023ج.م25.5bج.م41.6bج.م2.9b8.6x8.9x0.6x
Fri, 07 Apr 2023ج.م25.8bج.م41.1bج.م2.8b8.8x9.3x0.6x
Sun, 05 Mar 2023ج.م26.9bج.م40.6bج.م2.8b9.3x9.5x0.7x
Tue, 31 Jan 2023ج.م28.6bج.م40.4bج.م2.8b10x10.2x0.7x
Price to Earnings Ratio

10.2x


Total Market Cap: ج.م28.6bTotal Earnings: ج.م2.8bTotal Revenue: ج.م40.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Healthcare Sector Price to Earnings3Y Average 12.7x202420252026
Current Industry PE
  • Investors are optimistic on the Egyptian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 16.5x which is higher than its 3-year average PE of 12.7x.
  • The industry is trading close to its 3-year average PS ratio of 0.63x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 42% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare sector?

EG Market6.16%
Healthcare2.53%
Healthcare Services3.85%
Pharma1.46%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 24.0x.
    • Analysts are expecting annual earnings growth of 26.4%, which is lower than the prior year's growth of 71.8% per year.
  • Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 9.3x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 26% over the next 5 years.
  • However this is lower than its past earnings growth rate of 72% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 23% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ISPH Ibnsina Pharmaج.م11.4011.2%
+ج.م1.2b		70.1%PE16.3x
PHAR Egyptian International Pharmaceutical Industriesج.م78.252.5%
+ج.م317.3m		70.7%PE10.5x
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)ج.م3.203.2%
+ج.م200.0m		24.9%PE16.1x
CLHO Cleopatra Hospitals GroupEج.م12.591.0%
+ج.م188.4m		49.9%PE24.2x
BIOC GlaxoSmithKlineEج.م59.722.9%
+ج.م141.1m		49.9%PE50.7x

Latest News

BIOC
ج.م59.72
GlaxoSmithKlineE
7D
2.9%
1Y
49.9%
AXPH
ج.م790.23
Alexandria For Pharmaceuticals & Chemical Industries
7D
-1.2%
1Y
100.3%
ADCI
ج.م172.69
Arab Drug
7D
-1.9%
1Y
144.3%
ISPH
ج.م11.40
Ibnsina Pharma
7D
11.2%
1Y
70.1%
NIPH
ج.م94.25
EI- Nile for Pharmaceuticals and Chemical Industries
7D
2.5%
1Y
74.1%
SIPC
ج.م3.80
Sabaa International Company for Pharmaceutical and Chemical Industry
7D
13.8%
1Y
181.5%
MIPH
ج.م338.63
MINAPHARM Pharmaceuticals
7D
-1.7%
1Y
100.3%
PHAR
ج.م78.25
Egyptian International Pharmaceutical Industries
7D
2.5%
1Y
70.7%
CLHO
ج.م12.59
Cleopatra Hospitals GroupE
7D
1.0%
1Y
49.9%
CPCI
ج.م260.01
Kahira Pharmaceuticals & Chemical Industries
7D
-1.7%
1Y
137.1%
RMDA
ج.م3.20
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
7D
3.2%
1Y
24.9%